Tenofovir Disoproxil Fumarate
Active substance: tenofovir disoproxil
TABLET, COATED · TENOFOVIR DISOPROXIL FUMARATE 300 mg/1
United StatesActive
Marketing holder: Quinn Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- TENOFOVIR DISOPROXIL FUMARATE · 300 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 58 |
|
| EU 15 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3756-7c08-a002-015bd561b1f9,01a120c3-3fd2-7a1a-bbb1-f8ba75554f11,01a120c3-5f6e-79f4-8581-e3b76169c688,01a120c3-834b-7437-8f67-1196fed9f2bf,01a120c3-8eeb-758e-9ef6-7afa5379617f;count=18 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-59cf-796d-9a3f-9dab97a1f311,01a1208c-882f-7c0a-8acc-e50846bc5b6a,01a1208e-96ff-70d8-922c-c7c5afc84e51,01a1208e-aa42-7d1d-8124-89c3b88d2912,01a1208e-ac3e-79e8-b336-d6f8b29136f9;count=25 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 69076-105
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 69076-105 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69076-105 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69076-105 · Verified 2026-10-09 · open in source